Ionis Pharmaceuticals, Inc. Inventory, Raw Materials, Gross
Ionis Pharmaceuticals, Inc. (IONS) had Inventory, Raw Materials, Gross of $640.00 thousand as of 2025-03-31, per its 10-Q filed 2025-04-30.
Financial Statements › Notes
us-gaap:InventoryRawMaterials · last filed 2025-04-30
- 2025-03-31: Inventory, Raw Materials, Gross $640.00K.
- 2024-12-31: Inventory, Raw Materials, Gross $5.56M.
- 2024-09-30: Inventory, Raw Materials, Gross $21.74M.
- 2024-06-30: Inventory, Raw Materials, Gross $24.62M.
| Period end | Inventory, Raw Materials, Gross | Inventory, Raw Materials, Gross as first filed |
|---|---|---|
| 2025-03-31 | $640.00K 10-Q · filed 2025-04-30 | |
| 2024-12-31 | $5.56M 10-Q · filed 2025-04-30 | |
| 2024-09-30 | $21.74M 10-Q · filed 2024-11-06 | |
| 2024-06-30 | $24.62M 10-Q · filed 2024-08-01 | |
| 2024-03-31 | $24.02M 10-Q · filed 2024-05-07 | |
| 2023-12-31 | $1.81M 10-K · filed 2025-02-19 | $22.79M 10-K · filed 2024-02-21 |
| 2023-09-30 | $22.81M 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $23.25M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $20.14M 10-Q · filed 2023-05-03 | |
| 2022-12-31 | $19.76M 10-K · filed 2024-02-21 | |
| 2022-09-30 | $16.62M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $15.57M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $17.93M 10-Q · filed 2022-05-04 | |
| 2021-12-31 | $18.65M 10-K · filed 2023-02-22 | |
| 2021-09-30 | $16.14M 10-Q · filed 2021-11-03 | |
| 2021-06-30 | $21.59M 10-Q · filed 2021-08-04 | |
| 2021-03-31 | $18.20M 10-Q · filed 2021-05-05 | |
| 2020-12-31 | $16.71M 10-K · filed 2022-02-25 | |
| 2020-09-30 | $17.88M 10-Q · filed 2020-11-04 | |
| 2020-06-30 | $19.51M 10-Q · filed 2020-08-05 | |
| 2020-03-31 | $19.64M 10-Q · filed 2020-05-06 | |
| 2019-12-31 | $15.88M 10-K · filed 2021-02-24 | |
| 2018-12-31 | $8.50M 10-K · filed 2020-03-02 | |
| 2014-06-30 | $7.78M 10-Q · filed 2014-08-04 | |
| 2013-12-31 | $8.03M 10-Q · filed 2014-08-04 | |
| 2011-03-31 | $2.61M 10-Q · filed 2011-05-06 | |
| 2010-12-31 | $2.48M 10-Q · filed 2011-05-06 | |
| 2010-09-30 | $2.00M 10-Q · filed 2010-11-05 | |
| 2010-06-30 | $2.79M 10-Q · filed 2010-08-09 | |
| 2009-12-31 | $2.77M 10-K · filed 2011-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |